Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC HEPATITIS B”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07595159
What this trial is testing

BW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT00114361
What this trial is testing

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Foundation for Liver Research 138
Post-approval studies (Phase 4)Study completedNCT02081469
What this trial is testing

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Who this might be right for
Hepatitis B, ChronicTumor
Chang Gung Memorial Hospital 100
Not applicableStudy completedNCT02005146
What this trial is testing

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

Who this might be right for
Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues
Fundación Pública Andaluza Progreso y Salud 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT06537414
What this trial is testing

Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B Virus InfectionHepatitis B
GlaxoSmithKline 283
Early research (Phase 1)Study completedNCT05017116
What this trial is testing

A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Chronic Hepatitis B
Suzhou Ribo Life Science Co. Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT06115993
What this trial is testing

Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients

Who this might be right for
Hepatitis B, Chronic
Ausper Biopharma Co., Ltd. 129
Not applicableEnded earlyNCT01886300
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 16
Testing effectiveness (Phase 2)Study completedNCT00226447
What this trial is testing

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 30
Early research (Phase 1)Study completedNCT04168333
What this trial is testing

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B Virus (HBV)
Tasly Tianjin Biopharmaceutical Co., Ltd. 36
Not applicableStudy completedNCT05621304
What this trial is testing

Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)

Who this might be right for
Chronic Hepatitis B Virus (Hbv)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 274
Not applicableUnknownNCT06313255
What this trial is testing

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

Who this might be right for
Chronic Hepatitis B
Qilu Hospital of Shandong University 40
Testing effectiveness (Phase 2)Study completedNCT02751996
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

Who this might be right for
Hepatitis BHepatitis, Viral
F-star Therapeutics, Inc. 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797231
What this trial is testing

Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 930
Post-approval studies (Phase 4)UnknownNCT02365402
What this trial is testing

Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 180
Testing effectiveness (Phase 2)UnknownNCT04568265
What this trial is testing

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hep BHBV
Ascentage Pharma Group Inc. 122
Testing effectiveness (Phase 2)Ended earlyNCT02452528
What this trial is testing

Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus

Who this might be right for
Chronic Hepatitis B
Arrowhead Pharmaceuticals 4
Not applicableUnknownNCT03640728
What this trial is testing

The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

Who this might be right for
Hepatitis BVirus DiseasesLiver Failure
First Affiliated Hospital Xi'an Jiaotong University 200
Not applicableWithdrawnNCT01831037
What this trial is testing

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
University of Arkansas
Post-approval studies (Phase 4)Study completedNCT00641082
What this trial is testing

Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Who this might be right for
HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
Bukwang Pharmaceutical 43
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation